SGHT — Sight Sciences, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1531177 ·
Last close
$10.49
Market Cap
$583.02M
52W High
$11.60
52W Low
$3.38
ADV30
371,951
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 24,923,000 | 21,420,000 | -6,128,000 | -6,810,000 | 104,948,000 | 77,402,000 | 55,811,000 |
| Jun 2026 | 23,388,000 | 21,374,000 | -3,888,000 | -4,446,000 | 104,872,000 | 79,753,000 | 51,978,000 |
| Mar 2026 | 19,698,000 | 16,978,000 | -12,413,000 | -12,980,000 | 109,702,000 | 84,962,000 | 55,799,000 |
| Dec 2025 | 20,385,000 | 17,788,000 | -3,669,000 | -4,162,000 | 115,300,000 | 91,965,000 | 51,358,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-16,921,000
Investing CF
$9,000
Financing CF
$1,946,000
CapEx
$-317,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.52
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-408,959,000
Inventory
$6,502,000
Receivables
$13,380,000
ST Investments
—
EBIT TTM
$-23,181,000
Pretax Income TTM
$-28,340,000
Interest Exp TTM
$5,159,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$88,395,000
EBITDA
$-17,482,000
Free Cash Flow
$-2,159,375
Enterprise Value
$524,940,096
Total Cash
$77,402,000
Total Debt
$42,106,000
Shares Out
55,578,977
Trailing EPS
$-0.52
Book Value
$0.89
ROE
-50.1%
ROA
-10.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 77,363,000 | -37,099,000 | -38,426,000 | 115,300,000 | 51,358,000 | 63,942,000 | -29,694,000 |
| Dec 2024 | 79,866,000 | -50,532,000 | -51,507,000 | 142,839,000 | 55,316,000 | 87,523,000 | -22,351,000 |
| Dec 2023 | 81,056,000 | -57,274,000 | -55,547,000 | 166,651,000 | 46,436,000 | 120,215,000 | -47,184,000 |
| Dec 2022 | 71,331,000 | -83,954,000 | -86,242,000 | 213,073,000 | 52,997,000 | 160,076,000 | -75,965,000 |
TTM Snapshot
Revenues TTM
$83,377,000
NetIncome TTM
$-29,757,000
OpCashFlow TTM
—
Assets (Latest)
$104,872,000
Forward EPS
$-0.42
Max Pain — expiry 2027-05-21 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $10.77 · call volume: 51 · put volume: 0
Expected Move to 2027-05-21:
±$5.80
(53.85%) —
implied range
$4.97 –
$16.57
· ATM straddle on $10.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $583.56M | $26.05 | — |
| AVHHL | AVITA Medical, Inc. | $549.85M | $3.50 | — |
| OBIO | Orchestra BioMed Holdings, Inc. | $548.57M | $6.97 | — |
| AVR | Anteris Technologies Global Corp. | $518.67M | $5.32 | — |
| DCTH | DELCATH SYSTEMS, INC. | $673.84M | $19.37 | — |
News headlines (Yahoo Finance, 1h cache)
Sight Sciences (SGHT) Stock Gets Fair Value Boost After Q3 Beat And Guidance Raise
2026-11-17 06:12 · Yahoo
Sight Sciences, Inc. (SGHT) is a Great Momentum Stock: Should You Buy?
2026-11-12 16:00 · Yahoo
Sight Sciences to Present at Two Upcoming Investor Conferences
2026-11-05 21:05 · Yahoo
Sight Sciences (SGHT) Q3 2026 Earnings Call Transcript
2026-11-05 16:59 · Yahoo
Sight Sciences, Inc. Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
Sight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLids
2026-11-05 13:00 · Yahoo
Sight Sciences Inc (SGHT) (Q3 2026) Earnings Call Highlights: Record Revenue, Raised Guidance, ...
2026-11-05 05:17 · Yahoo
What Sight Sciences (SGHT) Said on Its Q3 Earnings Call
2026-11-05 05:14 · Yahoo
Sight Sciences (SGHT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
2026-11-05 00:00 · Yahoo
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates
2026-11-04 23:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.